Trending Across touchCARDIO

At a glance: education, conference reports and articles

CME & Education

Hypertension
touchEXPERT OPINIONS
Medical therapy for CTEPH: From biology to new treatment options
CME ACCREDITED Prof. Irene Lang (Austria), Prof. Marc Humbert (France), Dr Mark Toshner (UK) Watch Time: 30 mins

Watch leading experts involved in the care of patients with CTEPH discuss the latest issues and controversies in the medical management of CTEPH and related comorbidities

Learning objectives
Learning Objectives
  • Describe the biological and pathophysiological mechanisms of CTEPH
  • Summarize the evolving data supporting the use of oral therapies
  • Explain how new developments in medical therapy for the treatment of CTEPH will change daily practice
View All

Conference Hub

Arrhythmia
John Camm, HRC 2020 – The Digital A-A Heart Rhythm Congress 2020

Professor John Camm (President and Trustee of the Arrhythmia Alliance, HRC Scientific Editor) introduces the Digital A-A Heart Rhythm Congress (27-30 September 2020) and provides an overview of what to expect from this year’s meeting, the new opportunities opened by the digital format, who the meeting is geared towards and the benefits of Patient’s Day […]

View All

Learning Zone

Hypertension
touchEXPERT BRIEFING
Updates and new guidelines in statin therapy
Prof. Alberico Catapano, Dr Alan Brown, Prof. Kausik Ray Watch Time: 25 mins

Watch clinical specialists from Europe and the USA discuss techniques for the management and treatment of patients with high LDL-C levels, recorded during the ESC Congress 2019, Paris, France.

Learning objectives
Learning Objectives
  • Understand the importance of the ACC/AHA 2018 and ESC 2019 guidelines for management of blood cholesterol/dyslipidaemias with respect to clinical practice
  • Know the risks and benefits of statin treatment with respect to the risk for type 2 diabetes
  • Understand the potential for abnormal liver function and metabolic syndrome and be aware of drug-drug interaction as most statins are metabolized via the cytochrome P450 pathway
  • Know that the PROVE IT and REAL-CAD trials show that high-dose statin therapy is superior to moderate or low dose in cardiovascular event reduction
  • Understand that combination therapy gives an additional reduction in LDL levels and that statin dose should be titrated to risk
View All

Journals

Interventional Cardiology
The Coronary Sinus Reducer – Clinical Evidence and New Perspectives On An Emerging Tool in the Treatment of Refractory Angina
Carlo Zivelonghi, Stefan Verheye

Heart International. 2020;14(1):29-33 DOI: https://doi.org/10.17925/HI.2020.14.1.29

Refractory angina pectoris is a chronic disabling condition affecting an increasing number of patients (10–15%) with severe ischaemic heart disease.1 It is generally defined as the presence of debilitating angina due to severe and/or diffuse coronary artery disease (CAD), despite optimal medical therapy and with no option for further percutaneous or surgical revascularisation procedures. As […]

View All

More From CME & Education

View All

Learn more from touchCARDIO with CME-accredited and independent learning activities

Hypertension
touchPANEL DISCUSSION
Medical therapy for CTEPH: What is the standard of care in 2020?
Prof. Irene Lang, Prof. Nick Kim, Prof. Hiromi Matsubara Watch Time: 30 mins

Watch a panel of internationally renowned chronic thromboembolic pulmonary hypertension (CTEPH) experts discuss medical therapy for CTEPH, and consider the current standard of care using case-based studies to provide practical guidance on the optimal clinical management of patients with CTEPH.

Learning objectives
Learning Objectives
  • Discuss best practice for the multidisciplinary assessment of CTEPH
  • Apply medical therapy for inoperable patients with CTEPH
  • Perform medical therapy for patients with post-operative persistent/recurrent symptomatic disease
Hypertension
CME ACCREDITED
touchEXPERT OPINIONS
Medical therapy for CTEPH: From biology to new treatment options
Prof. Irene Lang (Austria), Prof. Marc Humbert (France), Dr Mark Toshner (UK) Watch Time: 30 mins

Watch leading experts involved in the care of patients with CTEPH discuss the latest issues and controversies in the medical management of CTEPH and related comorbidities

Learning objectives
Learning Objectives
  • Describe the biological and pathophysiological mechanisms of CTEPH
  • Summarize the evolving data supporting the use of oral therapies
  • Explain how new developments in medical therapy for the treatment of CTEPH will change daily practice

    • More From The Conference Hub

    View All

    View highlights and coverage from leading international Cardio congresses

    More From Learning Zone

    View All

    Medical education and communication on key topics in the area of Cardio. Content in this section is sponsored by the pharmaceutical industry.

    Hypertension
    touchEXPERT BRIEFING
    Updates and new guidelines in statin therapy
    Prof. Alberico Catapano, Dr Alan Brown, Prof. Kausik Ray Watch Time: 25 mins

    Watch clinical specialists from Europe and the USA discuss techniques for the management and treatment of patients with high LDL-C levels, recorded during the ESC Congress 2019, Paris, France.

    Learning objectives
    Learning Objectives
    • Understand the importance of the ACC/AHA 2018 and ESC 2019 guidelines for management of blood cholesterol/dyslipidaemias with respect to clinical practice
    • Know the risks and benefits of statin treatment with respect to the risk for type 2 diabetes
    • Understand the potential for abnormal liver function and metabolic syndrome and be aware of drug-drug interaction as most statins are metabolized via the cytochrome P450 pathway
    • Know that the PROVE IT and REAL-CAD trials show that high-dose statin therapy is superior to moderate or low dose in cardiovascular event reduction
    • Understand that combination therapy gives an additional reduction in LDL levels and that statin dose should be titrated to risk

    Latest Journal Articles

    View All

    Read the latest articles from our peer reviewed Cardio journals published by touchCARDIO

    Cardiovascular Disease
    Ratio of Serum Aspartate to Alanine Aminotransferase as a Marker of Isolated Coronary Artery Ectasia and its Severity
    Danesh Soltani, Samira Jafari, Amir Sobh-Rakhshankhah, Zahra Kolahchi, Farzad Masoudkabir, Mohammad Ali Boroumand, Ali Vasheghani-Farahani

    Heart International. 2020;14(1):43–8 DOI: https://doi.org/10.17925/HI.2020.14.1.43

    The exact aetiology of coronary artery ectasia (CAE) has yet to be fully elucidated; however, some underlying aetiologies such as atherosclerosis and microvascular abnormalities in coronary arteries have been proposed.1,2 Over the past few years, several inflammatory markers have been introduced as indicators of CAE and its severity. There is an association between the development of […]

    COVID-19
    Cardiovascular Effects of COVID-19 – What Do We Know and Where Should We Go?
    Matthew Ryan, Ozan Demir, Kevin O’Gallagher, Divaka Perera

    Heart International. 2020;14(1):16–9 DOI: https://doi.org/10.17925/HI.2020.14.1.16

    The current pandemic of coronavirus disease 2019 (COVID-19) is an unprecedented public health emergency, with worldwide health, social and economic implications. In contrast to other modern epidemics, little prior knowledge of the pathogen existed. Whilst this initially hampered both patient management and the public health response, we have observed a remarkable worldwide attempt to provide […]

    Interventional Cardiology
    Foreword – Heart International. 2020;14(1):8
    Magdi El-Omar, Rajesh Davé

    Heart International. 2020;14(1):8

    Dear colleagues, welcome to the summer issue of Heart International. We hope this reaches you well and that your personal and professional lives have not been affected adversely by the coronavirus pandemic. As is fitting for the current circumstances, we include an editorial by Prof. Perera’s group on the effects of COVID-19 on cardiovascular health. The […]

    Cardiovascular Disease
    Is There Still a Place for Revascularisation in the Management of Stable Coronary Artery Disease Following the ISCHEMIA Trial?
    Andre Briosa e Gala, Nick Curzen

    Heart International. 2020;14(1):13-5 DOI: https://doi.org/10.17925/HI.2020.14.1.13

    Optimal medical therapy (OMT) is the cornerstone of management in patients with coronary atheroma, given the substantial evidence that it can delay disease progression and damp down both chronic and acute vascular inflammation, thereby leading to a reduction in cardiovascular events and mortality.1,2 In this context, revascularisation, with either percutaneous coronary intervention (PCI) or coronary […]

    Want To Know More About Our Journals?

    Taking a balanced and practical view of the current clinical landscape in Cardio is at the heart of touchCARDIO and the journals we produce.

    The European Journal of Arrhythmia & Electrophysiology and Heart International are double-blind peer reviewed by at least two independent experts in the field to ensure articles are balanced, objective and relevant to the day-to-day clinical setting.

    Learn more about our journals

    Society & Congress Partners

    View All

    touchCARDIO is proud to partner with leading medical societies and congresses from around the world to bring you news and insight from virtual and live events
    Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar